bluebird bio Inc (NASDAQ:BLUE) broke out to a new 52-week high yesterday, accompanied by a good volume suggesting higher levels.

This biotech stock has been in a nice uptrend for the last seven months and technically looks very strong with both 50-day and 200-day exponential moving averages going up, while %K line is on top of %D line and MACD rising. BLUE is now on the overbought level, so this means a possible correction is near.

This potential pullback may give us a chance to jump in on the stock when it moves lower. Watchout for support at $100, as long as the stock does not go below this level on a possible correction phase, we are still safe. From a technical standpoint, this is a stock to keep an eye on for awhile.

This is a guest post by  António Costa, acclaimed trader and the popular author of AC Investor Blog.  All views and analysis belong to the author.

For the Social, Analyst and Sentiment perspective on BLUE and other stocks download our iOS or Android app.

António Costa
I'm a 43 year old Independent Trader using proprietary technical analysis with more than 18 years experience of investing in the US stock markets. I write guest posts for Stockal to share my thoughts about capital, risk management, and trading. My posts contains only my personal opinion and are provided for informational purposes only.

Leave a Reply

Your email address will not be published. Required fields are marked *